certican 0,1 mg disperģējamās tabletes
novartis baltics, sia, latvija - everolims - disperģējamā tablete - 0,1 mg
certican 0,75 mg tabletes
novartis baltics, sia, latvia - everolims - tablete - 0,75 mg
ciqorin 100 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - mīkstās kapsulas - 100 mg
finlepsin 200 mg tabletes
teva pharma b.v., netherlands - karbamazepīns - tablete - 200 mg
sunitinib teva 50 mg cietās kapsulas
teva b.v., netherlands - sunitinibs - kapsula, cietā - 50 mg
benemicin 300 mg cietās kapsulas
tarchomin pharmaceutical works "polfa" s.a., poland - rifampicīns - kapsula, cietā - 300 mg
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiski līdzekļi - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
everolimus krka 10 mg tabletes
krka, d.d., novo mesto, slovenia - everolims - tablete - 10 mg
everolimus krka 5 mg tabletes
krka, d.d., novo mesto, slovenia - everolims - tablete - 5 mg
everolimus krka 2,5 mg tabletes
krka, d.d., novo mesto, slovenia - everolims - tablete - 2,5 mg